Business Survey In India Genomics And Molecular Diagnostics Market Prospects To 2018 - Driven By Automation And Introduction Of New Technologies

India Genomics And Molecular Diagnostics Market Prospects To 2018 - Driven By Automation And Introduction Of New Technologies

The report titled ‘India Genomics and Molecular Diagnostics Market Prospects to 2018 – Driven by Automation and Introduction of New Technologies’ presents a comprehensive analysis of the industry aspects including market size by value of molecular diagnostics market in India. The report also entails the market share analysis and company profiles of major players operating in the molecular diagnostics market of India. The future analysis, trends and developments, government regulations and segmentation by application have also been discussed in the industry research report.

Download Full Report with TOC: http://www.marketresearchreports.biz/analysis-details/india-genomics-and-molecular-diagnostics-market-prospects-to-2018-driven-by-automation-and-introduction-of-new-technologies 

The advent of the latest inventions and technologies in accurate detection and quicker screening, and the prolific growth in genetic testing have driven the revenues of the Indian molecular diagnostics market in recent years. The increase in the number of patients stricken with infectious diseases have propelled the revenue growth in FY’2013, which has increased 14.3% to INR  million from INR  million in FY’2012.

Reagents led the revenues from the molecular diagnostics space with a percentage contribution of % of the total market in fiscal year 2013. The market has transformed from being a labor intensive to the inclusion of latest technologies. Majority of the reagents sales have historically been attributed to the diagnosis of infectious diseases such as tuberculosis, gonorrhea, Chlamydia and influenza virus, as well as the identification and predisposition to several conditions such as cancer and cystic fibrosis.

Visit Complete Report Here: http://www.marketresearchreports.biz/sample/sample/206247

The molecular diagnostics reagents market in India is segmented on the basis of application which includes virology tests, cancer detection, tuberculosis testing, blood screening, HPV testing and others. Molecular diagnosis helps in providing critical information that the healthcare providers and patients need in order to make the right decisions. Molecular diagnostics help in detecting and measuring the presence of genetic material which are associated with a specific health condition.

The molecular diagnostics market in India is majorly dominated by the virology tests market with a share of % in FY’2013. The infectious diseases such as HIV, HPV, hepatitis B and C and tuberculosis are prevalent in India. The combination of infectious disease immunoassay and molecular testing offers a complete solution for diagnosis and monitoring of HIV and hepatitis. Tuberculosis is one of the major causes of deaths among the people of India. Tuberculosis testing market held a share of % in FY’2013 which has grown from 14.3% in FY’2008. It has been observed that in 2012 about 1.3 million people in the world were killed due to tuberculosis and India accounted for 26% of the total TB cases globally. The rising number of tuberculosis cases in the country has contributed to a strong growth of TB testing in the molecular diagnostics market of India.

With the health insurance cover expected to increase, the health insurance industry is expected to integrate strongly with diagnostic centres. As the number of people having health insurance policies increases and outpatient diagnostics gets covered, health insurance companies will partner with diagnostic centres for standardized services. Products with superior technologies such as broader range application equipment and multitasking reagents will continue to find a deeper penetration in the Indian molecular diagnostics market. New technologies also will bring greater effectiveness to current methods. Technologies such as nanotechnology are likely to support the development of the molecular diagnostics field. The molecular diagnostic market is presently at its growing stage in the country and is expected to capture a significant share in the in-vitro diagnostics market in the coming years.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis/206247

Key Topics Covered in the Report:

• The market size of India molecular diagnostics market in terms of value
• India molecular diagnostics market segmentation by reagents and instruments
• India molecular diagnostics instruments market segmentation by fully automated and semi-automated analyzers
• India molecular diagnostics reagents market segmentation by application (virology tests, tuberculosis testing, cancer detection, blood screening tests, HPV testing and others)
• India molecular diagnostics  market segmentation by end users and manufacturers
• Market size of India virology tests using molecular diagnostics market
• Market size of India tuberculosis tests using molecular diagnostics market
• Market size of India cancer detection using molecular diagnostics market
• Market size of India molecular blood screening test market
• Market size of India molecular HPV tests market
• Market size of India other molecular tests market (genetic testing and industrial and food diagnostics)
• Trends and Developments and Government regulations in the molecular diagnostics market of India
• Market share of major players in India molecular diagnostics market
• Competitive landscape of India molecular diagnostics market
• Future projections and macro economic factors of India molecular diagnostics market


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact 
M/s Sheela 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-618-1030 
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/

Popular Market Report: Global Industry Prostatic Acid Phosphatase Testing Market Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Prostatic Acid Phosphatase Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Prostatic acid phosphatase (PAP) is a glycoprotein synthesized by the prostate gland and is also found in man’s semen; increased amount of PAP in men indicates prostate cancer, an abnormality of prostate gland. PAP tests are used to measure the amount of PAP in the blood, if the prostate gland is not working properly, then PAP is directly released into the blood, it shows the sign of bone metastases, a cancerous growth. The alternate names for a PAP test are TRAP test, and SAPT test. With increased expending power of people on healthcare, it has become important to put in efforts to detect and cure such cancers. PAP is one of the tests found in 1940s to detect prostate cancer. However, these tests have been replaced by prostate-specific antigen (PSA) tests to measure the prostate specific antigen in the blood. High levels of PSA in the blood indicates prostate cancer, also, an enlarged prostate gland may increase PSA levels.

To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/prostatic-acid-phosphatase-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Some of the factors which are considered for the PAP, PSA tests, such as age, the size of prostate, and the body mass index. With the increasing age, the level of PAP may increase substantially which is the reason men prefer to have a PAP test to detect prostate defects in advance. PAP levels fluctuate over the course of a day, and if these tests are normal, it eliminates the possibility of prostate cancer. PAP is less stable than PSA, there are many false negatives, these are few of the restraints to PAP test, and because of these problems PAP is no longer used for screening. 

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175972

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/175972

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
• It provides distinctive graphics and exemplified SWOT analysis of major market segments

Latest Reports:

Ion-Selective Clinical Lab Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/ion-selective-clinical-lab-analyzers-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019    

Ion-Selective analyzers consist of ion-selective electrodes that detect some specific ions in the presence of other ions and ion concentrations in an analytical solution, typically whole blood, plasma and serum. Ion-selective analysis also includes measurement of ion-concentrations of the detected specific ions and gases present in sample solution using certain probes, most commonly pH probe. Generally, metal ions such as the bromide, fluoride, cupric ions and cadmium, and dissolved gases like carbon dioxide, ammonia, nitrogen oxide, and oxygen are measured by using this technique. Ion-selective analyzers have the ability to retain the analysis data in the memory of analysis instrument and also provide calibration curves. Such ion-selective analyzers are designed to simultaneously measure electrolyte concentrations of ionized calcium, potassium, chloride, ionized magnesium, sodium and pH

The global ion-selective clinical lab analyzers market is categorized on the basis of:

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175970

Product types

• Ion-selective membranes
• Ion-specific electrodes
• Disposables
• Reagents

Applications

• Biosensors
• Blood gas analysis

Immunoassay Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/immunoassay-instruments-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019  

Immunoassays refer to biochemical tests or analytical techniques used to measure concentration of macromolecules in a solution with the help of antibody or immunoglobulin. The macromolecules refer to the analytes or proteins. These analytical methods are based on formation of antigen-antibody complex resultant of specific immuno reactions. Immunoassay techniques are specially suited for effective analysis of the compounds at low concentrations even at nanogram and picogram concentrations. High reliability, high sensitivity, applicability to diverse range of compounds, distinctive selectivity and detection at extreme low concentrations are some of the factors that make immunoassays a powerful tool and technique used for complex biological fluids such as blood, plasma or urine. These tests are widely employed in clinical, environmental and pharmaceutical fields. 

Click Here To Download Detail Report:  http://www.marketresearchreports.biz/analysis/175969

Immunoassays are performed in different formats and variations, namely, homogenous or non-separation immunoassays and separation or heterogeneous immunoassays. Homogeneous immunoassays are performed by mixing the sample and reagents followed by analysis whereas; heterogeneous assays may run in multiple steps by adding and washing away the reagents at different levels during an assay. Heterogeneous assays are also referred to as multi-step assays. With technological innovations leading to the development of novel products, immunoassay instruments market is bound to witness a tremendous growth in near future. Immunoassay instrument market can be segmented by technology, product type and geography. Presently, various immunoassay instruments are available commercially, for instance, ARCHITECT ci4100, ci8200, ci16200 (Abbott Diagnostics), Access/Access 2 Immunoassay System, UniCel DxC 660i Synchron Access Clinical System (Beckman Coulter), Clinical Diagnostics Group, EVOLIS (Bio-Rad Laboratories),  VIDAS Immunoassay Analyzer (bioMerieux) and others. 

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Blog: http://mrrfocuseconomics.blogspot.com/

Deep Research Report: Global Industry Companion Diagnostics Market Trends 2013 - 2019

Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019).

To Read the Complete Report with TOC Visit:  http://www.marketresearchreports.biz/analysis-details/companion-diagnostics-market-global-industry-size-market-share-trends-analysis-and-forecasts-2012-2018

The report also contains a section on market overview which consists of a detailed qualitative analysis of various market dynamics, such as drivers, restraints and opportunities. A section on market attractiveness analysis and Porter’s five force analysis for the companion diagnostics market has also been included.

Market share analysis of the leading players operating in the companion diagnostics market, in terms of % share for the year 2012, has been presented in the competitive landscape. The report also includes the list of recommendations for new market entrants. Some of the key market players profiled in this report include Roche Holdings AG, Abbott Laboratories, Genomic Health, Inc., Qiagen N.V., Life Technologies Corporation, Agilent Technologies, Inc. and GE Healthcare, Ltd.

To Buy The Copy of This Report Visit: www.marketresearchreports.biz/analysis/138982

The global companion diagnostics market is segmented into the following categories:

Companion Diagnostics Market, by Indications

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Gastric Cancer
• Melanoma
• Other (HIV, Thalassemia)

For More Information In Vitro Diagnostics Market Research Reports @ :

http://www.marketresearchreports.biz/category/28

Companion Diagnostics Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

About Us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://mrrfocuseconomics.blogspot.com/

Market study Report: Global Industry Hemostasis Diagnostics Market Growth 2013 - 2019

Hemostasis is the phenomenon of interaction between platelets, blood vessels and coagulation protein which helps to stop the bleeding. In addition, this process also maintains the blood flow in the blood vessels. Bleeding disorders could be a result of vascular and coagulation abnormalities. Hemostasis diagnostics helps in detection of these abnormalities and assists in proper treatment. Hemostasis diagnostic tests include Activated Partial Prothrombin Time (APPT), Prothrombin time (PT), and Fibrinogen assay. 

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/hemostasis-diagnostics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

PT test is performed by extraction of the blood sample and then blood cells are separated from the blood through centrifugation process. The patient’s plasma is then added to these cells to convert prothrombin to thrombin through tissue factors (V, VII and X) present in the plasma. This helps in detection of factors V, VII and X, Fibrinogen and Prothrombin in the blood sample. This test thus assists in the detection of hemostasis disorders. However in APPT, kininogen, prekallikrein are added to the blood cells which converts factor XI to XIa and helps in detection of any the abnormality related to the absence of XIa. In fibrinogen assay, plasma, bovine and imidazole buffered saline solutions are used to quantify fibrinogen content in blood sample.

Hemostasis disorder results in venous thromboembolism, acute coronary syndrome, dessiminated intravascular coagulation and postsurgical bleeding. Various cancers such as breast, kidney, liver, blood and lungs cancer are the major cause of hemostasis disorders. Amongst all these, liver cancer increases the risk of hemostasis disorders since it produces most clotting factors and inhibitors. In addition, it also produces numerous proteins which are involved in the process of fibrinoysis. In 2012, it has been estimated that around 120,000 people were suffering from liver cancer and is expected to grow exponentially. 

This exponential growth of liver cancer would augment the growth of hemostasis diagnostics market. Moreover, rise in aging population worldwide is increasing the accidental rate such as falling and injuries would also support the growth of this market. Hemostasis diagnostic tests are also performed prior to operation to test for quick healing process. This would also boost the growth of hemostasis diagnostic market worldwide.

Some of the market players in homeostasis diagnostic market globally include Abbott Laboratories, Siemens Inc., Beckman Coulter and Danaher Corporation, Instrumentation Laboratory and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World 

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/173421

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/